Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

NNIAGEN BIOSCIENCE, INC.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
N

NIAGEN BIOSCIENCE, INC.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • History
  • News
  • Insider Transactions

News

News

  • Newly Published Preclinical Study Demonstrates CD38 as a Driver of Age-Related NAD+ Decline, Older Mothers Have Lower NAD+ Levels in Placental Tissue, and NAD+ Restoration with Nicotinamide Riboside (NR) Improves Pregnancy Outcomes
    Sep 21, 2026Niagen Bioscience Press Releases
  • Niagen Bioscience Engages Veteran Pharmaceutical Executives and Biotechnology Experts to Support Drug Development Program and Strategic Business Growth
    Sep 17, 2026Niagen Bioscience Press Releases
  • Niagen Bioscience to Present at Canaccord Genuity’s Well Summit
    Sep 10, 2026Niagen Bioscience Press Releases
  • Niagen Bioscience to Present at Longevity Investors Conference
    Sep 2, 2026Niagen Bioscience Press Releases
  • Niagen Bioscience to Present at Nasdaq X LD Micro Inaugural SF Summit
    Aug 26, 2026Niagen Bioscience Press Releases
  • Niagen Bioscience Expands Tru Niagen® Retail Footprint with GNC and Sam’s Club
    Aug 20, 2026Niagen Bioscience Press Releases
  • Niagen Bioscience to Present at the 17th Annual Midwest IDEAS Investor Conference
    Aug 12, 2026Niagen Bioscience Press Releases
  • Niagen Bioscience Launches Tru Niagen on Walmart.com, Expanding Access and Diversifying Its E-commerce Marketplace Presence
    Aug 6, 2026Niagen Bioscience Press Releases
  • Niagen Bioscience, Inc. Reports Second Quarter 2026 Financial Results
    Aug 4, 2026Niagen Bioscience Press Releases
  • Niagen Bioscience Selects Global Drug Development Pioneer Evotec to Advance Preclinical Development for NB4168
    Aug 3, 2026Niagen Bioscience Press Releases
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • History
  • News
  • Insider Transactions
$2.98Close · Sep 28, 2026